Oral Administration of Bifidobacterium longum Ameliorates Influenza Virus Infection in Mice
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We investigated whether the oral administration of Bifidobacterium longum BB536 could ameliorate influenza virus (IFV) infection in a mice model. Mice were orally administrated BB536 or saline for 2 weeks and then infected with IFV. Orally administered BB536 significantly alleviated symptoms, reduced the loss of body weight, and inhibited viral proliferation in the lungs relative to the control group findings. Histopathological findings in the lungs were improved in the BB536 group compared to control group findings. There was no significant difference in the levels of interleukin-6 (IL-6), interferon-γ (IFN-γ), IL-10 and IL-12p40 in the lungs between the groups, but the levels of IL-6 and IFN-γ were lower (p=0.076, 0.103, respectively) in the BB536 group compared with those of control group. The levels of IL-6 and IL-10 correlated significantly with the values of weight loss, and the levels of IFN-γ correlated with the virus titers in the lungs. These results suggested the potential of the oral administration of BB536 in ameliorating IFV infection and the possible involvement of anti-inflammatory effects of BB536 in the anti-infection effects against IFV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired immune responses in the lungs of aged mice following influenza infection
Toapanta, F. R., & Ross, T. M. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-112 · Cited by 259
Maeda, N., Nakamura, R., Hirose, Y., Murosaki, S., Yamamoto, Y., Kase, T., & Yoshikai, Y. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.04.015 · Cited by 179
Cited by
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
Raheem, A., Liang, L., Zhang, G., & Cui, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616713 · Cited by 302
Commensal Bacteria: An Emerging Player in Defense Against Respiratory Pathogens
Khan, R., Petersen, F. C., & Shekhar, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01203 · Cited by 159
“Oral administration of Bifidobacterium longum (BB536), but not saline, in mice significantly reduced viral loads, pulmonary pathology, and body weight loss following intranasal challenge with influenza virus, suggesting a protective role for this commensal bacterium in influenza infection (33).”
BackgroundKawahara, T., Takahashi, T., Oishi, K., Tanaka, H., Masuda, M., Takahashi, S., Takano, M., Kawakami, T., Fukushima, K., Kanazawa, H., et al. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12210 · Cited by 125
Role of the intestinal microbiota in the immunomodulation of influenza virus infection
Chen, C.-J., Wu, G.-H., Kuo, R.-L., & Shih, S.-R. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.09.002 · Cited by 67
Shinde, T., Hansbro, P. M., Sohal, S. S., Dingle, P., Eri, R., & Stanley, R. (2020) · Microorganisms · doi:10.3390/microorganisms8060921 · Cited by 61
“B. longum strains have been demonstrated to cause changes in the level of specific Bifidobacterium species in the elderly that correlated with TNF-α, TGF-β, and IL-10 levels in serum [117].”
BackgroundInfluential
Metadata
- Authors
- Iwabuchi, N., Xiao, J.-Z., Yaeshima, T., & Iwatsuki, K.
- Venue
- Biological and Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2011
- Volume
- 34
- Issue
- 8
- Pages
- 1352-1355
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2105499941
- Cited by
- 66
- References
- 2
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.